GlassScriptPhysician profile
Kathleen E Hanover
NPI 1437504453
$11,122.99
in general payments reported to CMS, 2019-2025
31 companies · $2,513 in 2025
The $2,513 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $329 · 2021: $1,444 · 2022: $1,674 · 2023: $2,156 · 2024: $2,463 · 2025: $2,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,127 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,126.88 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,393.57 | 2019-2025 | |
| Abbvie INC. | $1,335.57 | 2019-2025 | |
| Ucb, INC. | $775.81 | 2020-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $683.35 | 2021-2025 | Dupixent, Libtayo |
| Pfizer INC. | $623.52 | 2020-2025 | |
| Lilly USA, LLC | $559.90 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Mayne Pharma Commercial LLC | $535.07 | 2022-2025 | |
| Incyte Corporation | $528.60 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $452.98 | 2020-2025 | Nemluvio, Aklief, Epsolay |
| Genzyme Corporation | $420.22 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $393.72 | 2021-2025 | Absorica Ld, Winlevi |
| Amgen INC. | $386.23 | 2020-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $383.71 | 2023-2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $347.79 | 2021-2025 | Cabtreo, Jublia |
| E.R. Squibb & Sons, L.L.C. | $308.96 | 2022-2025 | Sotyktu |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $282.36 | 2020-2025 | Adbry, Anzupgo |
| Allergan, INC. | $97.33 | 2019 | |
| Dermavant Sciences, INC. | $92.69 | 2023-2024 | Vtama |
| Almirall LLC | $91.26 | 2022-2024 | Klisyri |
| Vyne Pharmaceuticals INC. | $76.35 | 2020-2021 | |
| Smith+Nephew, INC. | $64.80 | 2025 | Collagenase Santyl |
| Organon LLC | $62.35 | 2025 | Vtama |
| Journey Medical Corporation | $39.27 | 2024 | |
| Arcutis Biotherapeutics, INC. | $31.80 | 2024 | Zoryve |
| Kerecis Limited | $30.02 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Chiesi USA, INC. | $29.22 | 2025 | Filsuvez |
| Epi Health, LLC | $21.78 | 2022 | |
| Integra Lifesciences Corporation | $21.55 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biofrontera INC. | $18.80 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Paratek Pharmaceuticals, INC. | $17.59 | 2022 | |
| Botanix Sb INC | $16.82 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Hanover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.